Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(12)
Published: Dec. 18, 2024
Abstract
Acute
kidney
injury
(AKI)
is
a
significant
global
health
issue,
which
often
caused
by
cisplatin
therapy
and
characterized
mitochondrial
dysfunction.
Restoring
homeostasis
in
tubular
cells
could
exert
therapeutic
effects.
Here,
we
investigated
Slc25a21,
carrier,
as
potential
target
for
AKI
intervention.
Renal
Slc25a21
expression
negatively
associated
with
function
both
patients
cisplatin-induced
murine
models.
Sustaining
renal
of
slowed
down
progression
reducing
cellular
apoptosis,
necroptosis,
the
inflammatory
response,
likely
through
its
regulation
2-oxoadipate
conversion.
highly
expressed
proximal
epithelial
cells,
down-regulation
contributes
to
compromised
biogenesis
integrity,
well
impaired
oxidative
phosphorylation.
Mechanistically,
reduced
disrupts
transport,
affecting
related
metabolites
influx
tricarboxylic
acid
cycle.
These
findings
demonstrate
previously
unappreciated
metabolic
suggest
that
targeting
sustaining
be
novel
strategy
AKI.
EBioMedicine,
Journal Year:
2024,
Volume and Issue:
107, P. 105294 - 105294
Published: Aug. 23, 2024
Acute
kidney
injury
(AKI)
is
a
clinical
syndrome
characterized
by
rapid
and
significant
decrease
in
renal
function
that
can
arise
from
various
etiologies,
associated
with
high
morbidity
mortality.
The
tubular
epithelial
cells
(TECs)
represent
the
central
cell
type
affected
AKI,
their
notable
regenerative
capacity
critical
for
recovery
of
afflicted
patients.
adaptive
repair
process
initiated
surviving
TECs
following
mild
AKI
facilitates
full
recovery.
Conversely,
when
severe
or
persistent,
it
allows
to
undergo
pathological
responses,
abnormal
phenotypic
transformation,
which
will
lead
development
fibrosis.
Given
implications
fate
after
outcomes,
deeper
understanding
these
mechanisms
necessary
identify
promising
therapeutic
targets
biomarkers
human
kidney.
Heliyon,
Journal Year:
2025,
Volume and Issue:
11(3), P. e42201 - e42201
Published: Jan. 23, 2025
Energy
metabolism
and
pyroptosis
are
integral
to
the
pathogenesis
of
diabetic
nephropathy
(DN).
However,
precise
roles
energy
in
DN
development
remain
unclear.
This
study
aims
elucidate
metabolism-
pyroptosis-related
differentially
expressed
genes
(EMAPRDEGs)
development.
EMAPRDEGs
were
identified
by
querying
GeneCards
Gene
Expression
Omnibus
(GEO)
databases.
Subsequent
analyses
included
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
enrichment,
Set
Enrichment
Analysis
(GSEA),
Protein-Protein
Interaction
(PPI)
network
analysis.
Additionally,
mRNA-miRNA,
mRNA-drug,
mRNA-transcription
factor
(TF)
interaction
networks
constructed.
Differential
expression
receiver
operating
characteristic
(ROC)
curve
performed
evaluate
diagnostic
potential
EMAPRDEGs.
Immune
cell
infiltration
was
assessed
using
ssGSEA
algorithm,
levels
tissues
validated
quantitative
real-time
PCR
(qRT-PCR).
Thirteen
identified,
with
GO
KEGG
indicating
their
involvement
pathways.
GSEA
revealed
significant
enrichment
these
biological
pathways
associated
nephropathy.
PPI
analysis
highlighted
central
role
within
relevant
Predictive
modeling
demonstrated
interactions
between
EMAPRDEGs,
69
miRNAs,
117
TFs.
showed
substantial
alterations
immune
populations,
ADH1B
PC
showing
a
correlation
natural
killer
cells
memory
B
cells.
ROC
confirmed
for
qRT-PCR
patterns
CASP1,
IL-18,
PDK4,
FBP1,
which
consistent
bioinformatics
predictions.
Bioinformatics
13
candidate
among
FBP1
emerge
as
biomarkers
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 27, 2025
Introduction
Chronic
nephrotoxicity
caused
by
CNIs
(CICN)
manifests
clinically
as
chronic
kidney
disease
(CKD).
Astragaloside
IV
(AS-IV)
plays
a
certain
role
in
the
treatment
of
CKD.
This
study
aimed
to
verify
ameliorative
effects
AS-IV
on
CICN
and
further
explore
mechanisms
underlying
modulation
“gut–transcriptome–metabolome
coexpression
network”
within
context
“gut–kidney
axis”
improve
CICN.
Methods
Five
groups
40
mice
were
studied:
normal
group
(N,
olive
oil),
model
(M,
CsA,
30
mg
kg
-−1
d
−1
),
low-dose
(CsA
+
AS-IV,
10
high-dose
20
valsartan
Val,
).
The
gut
microbiota,
renal
transcriptome,
urine
metabolome
separately
detected
construct
gut–transcriptome–metabolome
network.
target
species,
genes,
metabolites
evaluated.
Results
CsA
led
increased
proteinuria
deterioration
function,
accompanied
inflammation
oxidative
stress,
whereas
improved
damage.
inhibited
intestinal
permeability
disrupted
microbiota
structure,
increasing
abundance
Lactobacillus
reuteri
,
Bifidobacterium
animalis
Ignatzschineria
indica
Blautia
glucerasea.
Six
pathways
related
transcription
metabolism,
including
citrate
cycle
ascorbate
aldarate
metabolism
proximal
tubule
bicarbonate
reclamation
glycolysis/gluconeogenesis,
ferroptosis,
drug
metabolism–cytochrome
P450
identified.
Seven
identified
6
pathways,
UDP-D-galacturonic
acid,
2-phenylethanol
glucuronide,
dehydroascorbic
isopentenyl
pyrophosphate,
alpha-D-glucose,
3-carboxy-1-hydroxypropylthiamine
diphosphate
citalopram
aldehyde.
genes
Ugt1a2,
Ugt1a9,
Ugt1a5,
Pck1,
Slc7a11,
also
predicted
NONMMUT144584.1,
MSTRG.30357.1
ENSMUST00000174821.
was
highly
correlated
with
function
AS-IV.
validated.
intestinal-derived
urinary
toxins
tissue
apoptosis,
lipid
accumulation,
collagen
deposition,
mitochondrial
Conclusion
through
six
energy
driven
L.
alderate
tube
are
important
mechanisms.
Cell Biochemistry and Function,
Journal Year:
2025,
Volume and Issue:
43(5)
Published: May 1, 2025
ABSTRACT
Kidney
diseases,
characterized
by
renal
dysfunction,
are
the
leading
causes
of
death
worldwide.
It
is
crucial
to
prevent
and
treat
kidney
diseases
reduce
their
associated
morbidity
mortality.
Moderate
physical
exercise
has
been
recognized
be
advantageous
for
health.
Irisin
an
exercise‐induced
myokine
that
was
identified
in
2012.
plays
important
role
energy
bone
metabolism,
oxidative
stress
reduction,
anti‐inflammatory
processes,
cell
inhibition,
cardiovascular
protection.
However,
relationship
between
irisin
have
not
fully
elucidated.
This
review
explores
as
a
biomarker
disease
diagnosis
its
complications,
well
mechanisms
through
which
it
participates
various
pathways,
such
apoptosis,
autophagy,
pyroptosis,
ferroptosis.
Furthermore,
secretion
levels
were
discussed
provide
basis
prevention
treatment
avenues,
therapeutic
guidance
developing
new
promising
intervention
strategies.
Clinical
Trial
Registration
:
None.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(10), P. 2279 - 2279
Published: Oct. 8, 2024
:
Damage
to
renal
tubular
cells
(RTCs)
represents
a
critical
pathological
manifestation
in
calcium
oxalate
(CaOx)
stone
disease,
but
the
underlying
mechanism
remains
elusive.
Energy
metabolism
reprogramming
is
vital
influencer
of
RTC
survival,
and
SMYD2
histone
methylation
transferase
that
has
been
extensively
implicated
various
metabolic
disorders.
Hence,
this
research
aimed
identify
whether
induces
energy
RTCs
exposed
CaOx
nephrolithiasis.
Diabetes Metabolic Syndrome and Obesity,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 2789 - 2807
Published: July 1, 2024
Metabolic
reprogramming
contributes
to
the
progression
and
prognosis
of
various
kidney
diseases.
Glutamine
is
most
abundant
free
amino
acid
in
body
participates
more
metabolic
processes
than
other
acids.
Altered
glutamine
metabolism
a
prominent
feature
different
Glutaminolysis
converts
into
TCA
cycle
metabolite,
alpha-ketoglutarate,
via
cascade
enzymatic
reactions.
This
pathway
plays
pivotal
roles
inflammation,
maladaptive
repair,
cell
survival
proliferation,
redox
homeostasis,
immune
regulation.
Given
crucial
role
glutaminolysis
bioenergetics
anaplerotic
fluxes
pathogenesis,
studies
on
this
could
provide
better
understanding
diseases,
thus
inspiring
development
potential
methods
for
targeted
therapy.
Emerging
evidence
has
shown
that
targeting
promising
therapeutic
strategy
ameliorating
disease.
In
narrative
review,
equation
including
keywords
related
glutamine,
are
subjected
an
exhaustive
search
Pubmed
database,
we
identified
all
relevant
articles
published
before
1
April,
2024.
Afterwards,
summarize
regulation
major
diseases
its
underlying
molecular
mechanisms.
Furthermore,
highlight
strategies
their
clinical
applications.
Biofabrication,
Journal Year:
2024,
Volume and Issue:
17(1), P. 015040 - 015040
Published: Dec. 16, 2024
Kidney
damage
and
dysfunction
is
an
emerging
health
issue
worldwide
resulting
in
high
morbidity
mortality
rates.
Numerous
renal
diseases
are
recognized
to
be
driven
by
the
immune
system.
Despite
this
recognition,
development
of
targeted
therapies
has
been
challenging
as
knowledge
underlying
mechanism
complex
interactions
remains
insufficient.
Recent
advancements
field
offer
promising
avenues
for
exploring
interplay
between
cells
their
role
inflammation
diseases.
This
study
describes
establishment
a
human
immunocompetent
3D
vitro
co-culture
model
proximal
tubule
high-throughput
microfluidic
platform
that
can
used
functionality
inflammatory
processes.
The
incorporated
RPTEC
top
compartment
HUVECs
bottom
cultured
under
flow
direct
contact
with
collagen-I
ECM
gel
formation
polarized
tubular
structures.
As
component,
primary
monocytes
different
donors
were
added
lumen
endothelium.
Renal
was
successfully
induced
using
complement
activated
serum
(CAS)
evident
epithelial
morphological
changes,
increased
expression
adhesion
molecules,
release
pro-inflammatory
cytokines,
reduced
viability.
Realtime
migratory
behavior
showed
extravasation
migration
towards
upon
exposure
CAS
donor-to-donor
differences
observed.
Finally,
modulatory
compounds
efficacious
inhibition
monocyte
conditions
model.
A
successful
established
applied
disease
but
also
drug
screening
due
compatibility
automation
relatively
throughput.
Overall,
described
potential
fill
gap
currently
exists
preclinically.
.